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FREGLY, M. J., D. C. KIKTA AND J. E. GREENLEAF. Bethaneehol-induced water intake in rats: Possible
me('hanisms of induction. PHARMAC. BIOCHEM. BEHAV. 17(4) 727-732, 1982.--Acute administration of the
parasympathomimetic agent, bethanechol, at 2, 4, 8 and 12 mg/kg body wt, IP, induced drinking and increased urine output
of rats in a dose-dependent fashion. The first significant increases in both water intake and urine output above that of controls
occurred when 4 mg/kg was administered. The drinking and increased urine output in response to administration of 8 mg
bethanechol/kg was inhibited by atropine sulfate (3 and 6 mg/kg, IP). In addition, the/3-adrenergic antagonist, propranolol
(6 mg/kg, IP, administered 30 min prior to treatment with bethanechol), inhibited bethanechol (8 mg/kg, IP)-induced
drinking• Urine output, however, was unaffected by propranolol. Further, the angiotensin 1 converting enzyme inhibitor,
captopril, inhibited significantly the drinking response, but not the increased urine output, accompanying administration of
bethanechol (8 mg/kg). The effect of bethanechol and the/3-adrenergic agonist, isoproterenol (25 _g/kg) separately and in
combination, on water intake was also studied. Both compounds increased water intake but they exerted no interactive
effect when administered simultaneously. Administration of bethanechol (8 mg/kg) to conscious rats was also accompanied
by a significant reduction in both mean blood pressure and heart rate that reached minimal levels within 10 rain after
treatment. Both responses had returned to control level by one hr after treatment. These results suggest that bethanechol
induces drinking in rats by way of the renin-angiotensin system.
Parasympathomimetic agents Bethanechol Drinking Renin-angiotensin system
BOTH central and peripheral administration of parasym-
pathomimetic agents is well known to initiate drinking in rats
[ 1-6, 11]. Of the two routes of administration, the peripheral
route appears to initiate drinking less reliably [5]. Thus, the
dose-response relationship between dose of pilocarpine ad-
ministered and water intake during 90 minutes after treat-
ment was not linear and actually decreased when doses
higher than 3 mg/kg of body weight were administered intra-
peritoneally [5]. An initial objective was to find a parasym-
pathomimetic agent that could induce drinking more reliably
than pilocarpine when administered peripherally. Initial
studies with peripherally administered carbachol were un-
successfull in that increasing doses failed to induce drinking
and actually resulted in the death of several rats at the high-
est dose used (1 mg/kg, IP). Bethanechol, another parasym-
pathomimetic agent, was tested and found to induce dip-
sogensis in a dose-dependent fashion when graded doses
were administered to rats. Additional studies were then con-
ducted to assess by pharmacologic means whether the
renin-angiotensin system was involved in the drinking re-
sponse.
METHOD
Female rats of the Blue Spruce Farms (Sprague-Dawley)
slrain were used in all experiments. The rats ranged in
weight from 250 to 350 g at the beginning of the experiments.
All animals were kept in a thermoregulated (26_+ i°C) room
illuminated from 7 a.m. to 7 p.m. Purina Laboratory Chow
and tap water were provided ad lib. All drinking studies were
performed in a quiet, thermoregulated (26_+ I°C) room be-
ginning at 9:30 a.m. Water was used to dissolve all com-
pounds administered in these studies.
Experiment I: Lffect of Carbamyl-_-MethyI-Choline
Chloride (Bethanechol) on Water bttake
Thirty naive female rats (280--330 g) were divided ran-
domly into five equal groups. Groups 1 through 4 received
bethanechol at 2, 4, 8 and 12 mg/kg, IP. Group 5 served as
control and received the vehicle used to dissolve
bethanechol. After administration of the drugs, each rat was
placed in an individual stainless steel metabolism cage and
given a preweighed water bottle containing distilled water
[10]. Water intake and urine output were measured at hourly
intervals for three hr. The three urine samples of each rat
were pooled and analyzed for their sodium and potassium
concentrations by flame photometry.
Analysis of the data was made by a one-way analysis of
variance [13]. Comparison between individual means was
made by the t-test using the pooled variance from the
analysis of variance [7].
Experiment 2: Effect of Atropine on Bethanechol-lndttced
Water Intake
Twenty-four naive female rats (290 to 350 g) were divided
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intofourequalgroups.Groups1-3receivedbethanechol(8
mg/kg,IP)whilethesecond,andthirdgroupsalsoreceived
thecholinergicreceptorantagonist,a ropinesulfate,at3and
6mg/kg,IP, respectively.Theremaininggroupservedas
controlandreceivedthevehicleusedto dissolveboththe
bethanecholandatropine.Atropinewasadministered15min
priortoadministrationfbethanechol.Afteradministration
of thecompounds,eachratwasplacedinastainlesssteel
metabolismcageandgivenapreweighedbottleofdistilled
water.Waterintakeandurineoutputsweremeasuredat
hourlyintervalsforthreehrthereafter.Urinarysodiumand
potassiumconcentrationsweremeasuredbyflamephoto-
metryontheurinecollectedfromeachratduringtheentire
threehroftheexperiment.
AnalysisofthedatawasmadeasdescribedinExperiment1.
Experiment 3: Effect of Propranolol on Bethaneehol-
Induced Water Intake
The same 24 rats used in Experiment 2 were used in this
experiment. One week elapsed between experiments. The
rats were divided randomly into four equal groups. Group 1
received bethanechol (8 mg/kg, IP) while the second and
third groups received bethanechol in combination with 3 and
6 mg d,l-propranolol-HC1/kg, IP, respectively. Propranoiol,
a fl-adrenoreceptor blocker, was administered 30 min prior
to administration of bethanechol. The remainder of the ex-
periment was carried out identically to that of Experiment 2.
Experiment 4." Effect of Captopril on Bethaneehol-lndaced
Water Intake
The same rats used in Experiment 3 were used in this
experiment. One week elapsed between experiments. The
rats were divided randomly into four equal groups. Group 1
received bethanechol (8 mg/kg, IP) while the second group
received captopril, an angiotensin I converting enzyme in-
hibitor (35 mg/kg, IP). The third group received both
bethanechol and captopril while the fourth group was ad-
ministered the vehicle used to dissolve both captopril and
bethanechol and served as control. Both compounds were
administered at the same time. The remainder of the experi-
ment was carried out identically to that described in Experi-
ment 2.
Data from this study were analyzed by a two-way analysis
of variance to assess the effect of treatment with each com-
pound as well as their interaction [13].
Experiment 5: Effect of Administration of lsoproterenol and
Bethanechol, Ahme and Combined, on Water Intake
Twenty four naive rats (235 to 275 g) were divided ran-
domly into four equal groups. Group 1 was administered
d,l-isoproterenol HC1, a fl-adrenergic agonist (25/xg/kg, SC)
while Group 2 received bethanechol (8 mg/kg, IP). Group 3
received both compounds simultaneously while Group 4 re-
ceived the vehicle used to dissolve both compounds. The
remainder of the experiment was carried out as described in
Experiment 2 except that urine output and urinary excretion
of sodium and potassium were not measured.
Data from this study were analyzed by a two way analysis
of variance as described in Experiment 4.
Experiment 6: Effect of Bethaneehol on Blood Pressure and
Heart Rate of Conscious Rats
Six female rats (260 to 290 g) were used. Each rat had an
indwelling carotid arterial cannula that had been in place for
several weeks prior to the study. Blood pressure was moni-
tored continuously by attaching the cannula to a Statham
P23Db pressure transducer which was coupled to a Grass
polygraph. The conscious, unrestrained rats were kept in
their cages throughout the experiment. Heparinized saline
(100 U/ml) was used in all cannulae to keep them patent.
On the day of the study, two groups of rats (3 each) were
used. After an initial control period lasting 30 minutes, either
saline or bethanechoi (8 mg/kg) was administered IP. Both
blood pressure and heart rate were measured at the end of
the control period and 1, 3 and 5 min after treatment with
bethanechol and at 5 rain intervals thereafter for 55 min.
RESULTS
Experiment 1
Administration of graded doses of bethanechol increased
water intake during the first hr in a dose-dependent fashion
up to the highest dose administered (12 mg/kg, Table 1). The
first significant (p<0.05) increase in water intake occurred
when a dose of 4 mg/kg was administered. The smaller water
intake accompanying administration of the highest dose of
bethanechol was apparently related to toxicity. During the
second hr when the toxic manifestation had subsided, water
intake more than doubled that observed during the first hr. A
further increase in the water intake of this group, which was
considerably in excess of that observed for any of the other
treated groups, occurred during the third hr of the experi-
ment.
Urine output also increased in a dose-dependent fashion
during the three hr of the experiment (Table !). Both urinary
sodium and potassium excretions also increased with in-
creases in the dose of bethanechol administered. The in-
creases in urinary sodium and potassium excretion occurred
in roughly similar amounts since the urinary Na/K ratio of
any one of the treated groups failed to differ significantly
from that of the control group.
Experiment 2
Administration of atropine sulfate at either 3 or 6 mg/kg,
IP, inhibited the increased water intake induced by
bethanechol (Table 2). Both doses appeared to be equally
potent in this regard. The inhibitory effect of atropine per-
sisted throughout the three hr of the experiment. In addition,
the increased urinary output induced by bethanechol was pre-
vented by administration of either dose of atropine as was
the increased urinary sodium and potassium output.
Experiment 3
Administration of the /3-adrenergic antagonist, d,I-
propranolol, inhibited the increased water intake induced by
bethanechol (Table 3). The higher dose of propranolol (6
mg/kg) inhibited water intake to a greater extent than the
lower dose (3 mg/kg). The effect of the higher dose of pro-
pranolol persisted throughout the three hr of the experiment.
Administration of propranolol in combination with be-
thanechol failed to affect the increased urine output and the
increased urinary sodium and potassium excretion rates in-
duced by bethanechol. Urinary Na/K ratios of all treated
groups were significantly (p<0.01) greater than that of con-
trois.
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TABLE I
EFFECT OF CARBAMYL/3-METHYL-CHOLINE (BETHANECHOLI ON WATER INTAKE, URINE OUTPUT, AND URINE ELECTROLYTE
EXCRETION BY FEMALE RATS
Cumulative Cumulative
Water Intake Urine Output
(mt/kg body wt.) (ml/kg body wt.) Urinary Urinary
Number Mean during during Na K Urinary
Experimental of Body Excretion Excretion Na/K
Group Rats wt. (g) 1 2 3 hr' 1 2 3 hr lmEq/kg/3 hr) (mEq/kg/3 hr) Ratio
Control 6 325 1.8 2.2 2.8 1.2 1.2 1.2 0.20 0.12 1.66
+ + ± .+_ ± ± ± ± + ±
8* 0.3 0.2 0.2 0.5 0.5 0.5 0.05 0.01 0.44
Bethanechol 6 322 2.3 2.8 3.5 1.9 2.7 3.6 0.53 0.18 2.81
(2 mg/kg, + -+ -+ -+ -+ -+ + -+ + +-
IP) 5 1.2 1.2 1.2 0.7 1.0 1.1 0.16 0.04 0.38
Bethanechol 6 308 5.3 5.8 6.4 3.6 4.3 5.8 0.49 0.23 2.25
(4 mg/kg, + -+ -+ -+ + -+ -+ -+ +- -+
IP] I I 0.9+ 0.9+ 0.9+ 1.0 1.0 0.95 0.08 + 0.03, 0.36
Bethanechol 6 3 I0 9.8 11. I 11.7 4.8 5.4 8.6 0.77 0.29 2.72
{8 mg/kg, + + ± -+ + -+ ± + -+ +-
IP) 6 1.85 2.6._ 2.6 + 2.6 0.8:[: 1.1- 0.175 0.015 0.48
Bethanechol 6 322 5.1 12. I 14.2 7.5 8.5 I 1.6 0.75 0.42 2.12
[ 12 mg/kg -+ ± -+ -+ +- -+ + -+ -+ -+
IP) 14 2.8 2.9+ 3.0+ 1.65 1.4+ 2.75 0.125 0. I I+ 0.29
*One standard error of mean.
+Significantly different from Control (O<0.05).
+Significantly different from Control (O<0.01).
TABLE 2
EFFECT OF CARBAMYL/3-METHYL-CHOLINE (BETHANECHOL) AND ATROPINE SULFATE ALONE AND IN COMBINATION. ON WATER
INTAKE, URINE OUTPUT AND URINE ELECTROLYTE EXCRETION BY FEMALE RATS
Cumulative Cumulative
Water Intake Urine Output
{ml/kg body wt.) (ml/kg body wt.) Urinary Urinary
Number Mean during during Na K Urinary
Experimental of Body Excretion Excretion Na/K
Group Rats wt. (g) 1 2 3 hr 1 2 3 hr (mEq/kg/3 hr) (mEq/kg/3 hr) Ratio
Control
Bethanechol
(8 mg/kg,
IP)
Bethanechol
+ Atropine
(3 mg/kg,
IP)#
Bethanechol
+ Atropine
(6 mg/kg,
IP)#
6 329 1.4 1.7 2.2 2.0 2.9 3.3 0.32 0.29 1.24
± ± ± ± ± + ± _+ _ ±
9* 0.4 0.5 0.5 0.9 1.1 1.2 0.04 0.09 0.24
6 322 9.4 11.7 12.4 4.7 5.8 8.3 0.77 0.64 1.26
+ -+- + + ± _+ ± ± -+- ±
11 2.1:_ 1.4+ 1.4+ 0.7 t 0.9 + 0.9:_ 0.08+ 0.07+ 0.18
6 324 2.9 2.9 3.4 0.0 0.0 0.9 0.00 0.00 0.00
15 1.3¶ 1.3¶ 1.4¶ 0.0+¶ 0.0:I:¶ 0.9¶ 0.00:l:¶ 0.00+¶ 0.00
6 316 2.0 2.2 3.0 0.9 2.1 2.1 0.27 0.31 0.85
6 0.4¶ 0.5¶ 0.5¶ 0.7¶ 1.1§ 1.2¶ 0.06 0.05 0.04
*One standard error of mean.
+Significantly different from Control (p<0.05).
+Significantly different from Control (p <0.01).
§Significantly different from Bethanechol (o<0.05).
¶Significantly different from Bethanechol (O<0.01).
#Atropine sulfate given 15 minutes before Bethanechol.
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TABLE 3
EFFECT OF CARBAMYL fl-METHYL-CHOLINE (BETHANECHOL) AND PROPRANOLOL, ALONE AND IN COMBINATION, ON WATER
INTAKE, URINE OUTPUT AND URINE ELECTROLYTE EXCRETION BY FEMALE RATS
Cumulative Cumulative
Water Intake Urine Output
(ml/kg body wt.) (ml/kg body wt.) Urinary Urinary
Number Mean during during Na K Urinary
Experimental of Body Excretion Excretion Na/K
Group Rats wt. (g) l 2 3 hr I 2 3 hr (mEq/kg/3 hr) (mEq/kg/3 hr) Ratio
Control
Bethanechol
(8 mg/kg,
IP)
Bethanechol
4- Propranolol
(3 mg/kg,
IP)¶
Bethanechol
+ Propranolol
(6 mg/kg,
IP)¶
6 311 2.5 3.0 3.6 1.0 1.8 3.3 0.22 0.32 0.67
_+ _+ + + + + + + + ±
I 1" 0.9 0.9 0.9 1.0 1.5 1.4 0.05 0.05 0.09
6 328 10.3 11.8 12. I 5.7 6.8 8.8 0.79 (I.59 1.86
I 1 2.5t 1.9:1: 1.9:_ 1.35 1.5:1: 1.85 0.17:t: 0.13_- 0.545
6 325 5.2 8.1 9.6 6.8 7.7 9.3 0.78 0.56 1.56
_+ ± ± ± ± _+ + + + ±
15 3.2 2.9 2.9 1.5 1.6 1.7 0.132 0.115 0.273
6 316 2.0 2.2 3.0 4.4 6.1 2.1 0.83 0.58 1.48
± _+ + + ± _+ _+ + + _+
5 0.2§ 0.6§ 0.6§ 1.1 1.4 1.2 0.132 0.122 0.085
*One standard error of mean.
tSignificantly different from Control (p <0.05).
_:Significantly different from Control (O<0.01).
§Significantly different from Bethanechol (o<0.05).
¶Propranolol given 30 minutes before Bethanechol.
TABLE 4
EFFECT OF CARBAMYL fl-METHYL-CHOLINE (BETHANECHOL) AND CAPTOPRIL, ALONE AND IN COMBINATION, ON WATER INTAKE,
URINE OUTPUT AND URINE ELECTROLYTE EXCRETION BY FEMALE RATS
Cumulative Cumulative
Water Intake Urine Output
(ml/kg body wt.) (ml/kg body wt.) Urinary Urinary
Number Mean during during Na K Urinary
Experimental of Body Excretion Excretion Na/K
Group Rats wt. (g) 1 2 3 hr I 2 3 hr (mEq/kg/3 hr) tmEq/kg/3 hr) Ratio
Control 6 305 1.8 2.8 3.2 0.3 0.3 1.1 0.27 0.16 1.65
+ + + _a- + + ± + _+
4* 0.4 0.6 0.6 0.2 0.2 0.5 0.03 0.01 0.06
Bethanechol 6 322 9.9 10.5 11.1 3.7 5.0 7.2 0.66 0.66 1.01
(8 mg/kg, _+ _+ _+ + + _+ _+ + _+ +-
IP) 4 2.7 2.7 2.7 0.9 0.8 1.6 0.04 0.04 0.05
Captopril 6 321 1.3 2.9 5.0 0.9 2.5 2.7 O. 16 0.21 0.76
(35 mg/kg, _+ _+ _+ _+ _+ + _+ + _+ _+
IP) 6 0.5 0.7 i.2 0.4 0.9 0.3 0.04 0.04 0.12
Bethanechol 6 321 2.1 5.6 8. ! 6.4 6.9 8.6 0.79 0.68 1.09
+ Captopril _+ _+ _+ _+ +_ _+ _+ + _+ +
12 1,5 1.7 2.4 0.7 0.6 1.0 0.05 0.05 0.07
Significance--Two Way ANOVA
Bethanechol NS <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 <0.01 NS
Captopril NS <0.01 NS NS <0.05 <0.05 NS NS NS <0.01
Interaction NS <0.05 NS NS NS NS <0.01 NS NS <0.01
*One standard error of mean.
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FIG. I. Effect of administration of isoproterenol and bethanechol,
alone and in combination, on water intake during the first (A) and
second (B) hours after treatment. One standard error is set off at
each mean.
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Experiment 4
Administration of the angiotensin I converting enzyme
inhibitor, captopril (35 mg/kg), inhibited the increased water
intake induced by bethanechol (Table 4). The effect of cap-
topril was greatest during the first hr after treatment. Its
effectiveness waned considerably during the second and
third hr of the experiment. Captopril alone was without sig-
nificant effect on water intake. The increased urine output
and increased urinary sodium and potassium excretion rates
induced by bethanechol were unaffected by simultaneous
treatment with captopril.
Experiment 5
When isoproterenol (25 /zg/kg, SC) and bethanechol (8
mg/kg, IP) were administered alone, both induced a signifi-
cant increase in water intake during the first and second hr
after treatment (Fig. 1). When administered together, the
effects of the two treatments were additive and not inter-
active as determined by a two way analysis of variance.
Experiment 6
Administration of bethanechol (8 mg/kg, IP) to conscious
rats with an indwelling carotid cannula was accompanied by
a reduction in mean blood pressure of approximately 40 mm
Hg (Fig. 2A). The maximal depression occurred at approx-
imately 10 rain after treatment after which mean blood pres-
sure returned toward that of controls. By 30 min after treat-
ment, mean blood pressure of the treated group was no
longer significantly different from that of the control group.
Heart rate after administration of bethanechol followed a
time-course that was similar to that of mean blood pressure
(Fig. 2B).
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FIG. 2. Effect of administration of bethanechol on mean blood pressure (A) and heart rate (B) of conscious rats having an
indwelling cannula in one carotid artery. One standard error is set off at each mean.
732 FREGLY,KIKTAAND GREENLEAF
DISCUSSION
Peripheral administration of graded doses of the
parasympathomimetic agent, bethanechol, to rats was ac-
companied by a graded increase in water intake which oc-
curred within an hr after treatment. The first significant ef-
fect occurred when a dose of 4 mg/kg was administered. The
highest dose of bethanechol (12 mg/kg) may have induced
adverse effects since this group drank considerably less
water during the first hr of the study than the group adminis-
tered 8 mg/kg. However, the effect of the highest dose of
bethanechol on water intake manifested itself during the sec-
ond hr of the study when, presumably, the adverse effect had
subsided.
A previous study from this laboratory using pilocarpine
also revealed that it stimulated water intake when adminis-
tered peripherally to rats. However, the side effects, includ-
ing diarrhea, appeared subjectively to be more prevalent
with pilocarpine than bethanechol. Further, Gay et al. [5]
reported that drinking accompanying administration of
pilocarpine to rats depended in part on the dose administered
and on the time after administration that measurements were
made. Maximal drinking response to graded IP doses of
pilocarpine was observed at 3.75 mg/kg. Doses higher that
this (7.5, 15 and 30 mg/kg) progressively reduced the drink-
ing response during the first 90 rain of the study. By 180 min
after treatment, a dose-response relationship appeared [5]. A
further interesting aspect of their study was that administra-
tion of 1 mg of either scopolamine or methyl scopolamine/
kg failed to affect pilocarpine-induced drinking and
scopolamine may actually have enhanced it. In addition,
methyl atropine (2.0 mg/kg) failed to affect pilocarpine-
induced water intake. In contrast, administration of either
3.0 or 6.0 mg atropine sulfate/kg inhibited bethanechol-
induced drinking. The drinking responses induced by
pilocarpine and bethanechol would appear to differ in at least
this important respect. Unpublished studies from this labora-
tory have shown that atropine sulfate (6.0 mg/kg, IP) had no
effect on the water intake of rats during the course of a 3
hour experiment.
Administration of bethanechol was always accompanied
by an increased urine output and urinary sodium excretion
(Tables 1-4). Similar results have been reported to accom-
pany peripheral administration of pilocarpine, as well as cen-
tral administration of carbachol, to rats [4,12]. In contrast to
the effect of peripheral administration of pilocarpine, the
first significant increases in both urine output and water in-
take accompanying peripheral administration of bethanechol
occurred at the same dose. In the case of pilocarpine, urine
output increased at a lower dose than that inducing water
intake [4]. Whether the effects of administration of parasym-
pathomimetic agents on renal sodium excretion are man-
ifested at the level of the kidney or elsewhere is unknown.
While changes in renal hemodynamics resulting from the re-
duction in blood pressure accompanying administration of
bethanechol may play a role, a reduction in glomerular fil-
tration rate would be expected to reduce, rather than in-
crease, renal sodium loss. Other factors are more likely to
contribute to the increased renal sodium loss. In this regard
it is of interest that atropine blocked the natriuretic effect of
bethanechol while propranolol and captopril did not. This
suggests that the natriuretic effect of bethanechol is a direct
result of its parasympathomimetic activity.
The mechanism by which administration of bethanechol
increases water intake appears most likely to occur by way
of the renin-angiotensin system. Bethanechol may act di-
rectly at preganglionic sympathetic nerve terminals to initi-
ate the release of catecholamines from the adrenal medulla
and thereby stimulate the release of renin from the kidney. It
is also likely that release of renin is reflexly initiated by the
fall in blood pressure accompanying its administration (Fig.
2). The drinking response to administration of bethanechol is
inhibited by concurrent treatment with either the
/3-adrenoreceptor antagonist, propranolol, or the angiotensin
I converting enzyme inhibitor, captopril. These results also
suggest that the renin-angiotensin system contributes to the
bethanechol-induced water intake. Other studies have
shown that both propranolol and captopril, administered
alone at the doses used here, failed to affect water intake of
rats [8,9].
A furhter suggestion that bethanechol-induced water in-
take uses a pathway similar to that of isoproterenol is found
in the data from Experiment 5 in which these compounds
were administered singly and together (Fig. 1). The effect of
simultaneous administration of the two compounds was ad-
ditive rather than interactive. Thus, separate pathways for
mediation of the .two drinking responses are unlikely.
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